Human Papilloma Virus DNA Self-Test (HPV)
Status
Conditions
Details and patient eligibility
About
HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?
Full description
Women between the ages of 18 years to post-menopausal with documented abnormal pap smear atypical squamous cells of undetermined significance and higher will be enrolled into the study. Patients will be taught how to collect vaginal samples with dacron swab and vaginal tampons by means of instructional video and manufacturer's instruction guide respectively. Physicians will perform pap smear and colposcopy. All samples will be sent to the University of Louisville lab for processing for HPV DNA detection by Hybrid capture 2 method.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Abnormal pap smear ASCUS or higher
Age 18-postmenopausal
Exclusion criteria
Less than 18 years old
Prior hysterectomy
Pregnancy
Use of corticosteroids
HIV positive
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal